ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

Laura Q M Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.